SEC Filing Summary: Hexindai Inc. (Form 6-K)
Business Context and Reporting Period
This Form 6-K was filed by Hexindai Inc., a foreign private issuer, for the month of January 2019. The report was signed by Zhang Qisen (Johnson), Chief Financial Officer, on January 18, 2019. The registrant's principal executive office is located in Beijing, People's Republic of China. The filing serves as a report pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document consists primarily of cover page information and an exhibit index.
Material Changes
The filing text does not provide a clear value regarding material changes versus the prior comparable period. No comparative financial data or operational updates are included in the provided text.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The only substantive content referenced is Exhibit 99.1, described as a "Press Release," the text of which is not included in the input.
Key Facts for Investor Verification
- The registrant is Hexindai Inc., not Akso Health Group as indicated in the request metadata.
- The filing is a Form 6-K dated January 18, 2019, covering the month of January 2019.
- Financial performance data is absent from the provided text; investors must review the referenced Press Release (Exhibit 99.1) for details.
- The company files annual reports under Form 20-F.